Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
CHMP issues positive opinion for TECFIDERA™ (dimethyl fumarate) as a first-line treatment for multiple sclerosis in the European Union
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.
Neurotrophic and Neuroprotective effects of muscle contraction.
European Medicines Agency accepts Marketing Authorization Application for conditional approval of masitinib in the treatment of pancreatic cancer
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
Clinically isolated syndromes.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Tract-specific and age-related variations of the spinal cord microstructure: a multi-parametric MRI study using diffusion tensor imaging (DTI) and inhomogeneous magnetization transfer (ihMT).
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
Cervical cord and ventricle affection in neuromyelitis optica.
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Gastro Effects Dog Oral MS Drug Tecfidera
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination.
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
Zebrafish as a model to investigate CNS myelination.

Pages